CHICAGO, June 13 /PRNewswire/ -- The Emergency Nurses Association (ENA)
today announced that PDL BioPharma has been named a strategic partner for
2007. As a strategic partner, PDL BioPharma will be the exclusive sponsor
for the ENA State Leaders December Orientation and the Emergency Nurses
Week, October 7-13, 2007.
"We are very pleased to announce this partnership with PDL BioPharma,"
said Donna Mason, RN, MS, CEN, ENA President. "By partnering with ENA, PDL
BioPharma gets a unique opportunity to show their support of the life
saving work of emergency nurses across the county."
Through this partnership, PDL BioPharma will help finance ongoing
educational and professional networking activities, as well as events
honoring nurses during emergency nurses week.
"As a company committed to discovering, developing and marketing
innovative therapies that will positively impact patients' lives, PDL
BioPharma has great respect for emergency nurses' commitment to patients,
which is exemplified by the extraordinary work they do in emergency
departments everyday," said Jaisim Shah, senior vice president, marketing
and business affairs, PDL BioPharma Inc. "Like our treatments for
short-term hypertension treatment and acute myocardial infarction, these
healthcare professionals are saving lives everyday. Through this
partnership, we hope to raise the visibility of emergency nurses while
showing our appreciation for everything that they do."
In the United States and Canada, PDL BioPharma markets several
commercial biopharmaceutical products for the hospital setting --
Cardene(R) I.V. (http://www.pdlbiopharma.com/index.cfm?navid=32) for the
short-term treatment of hypertension, Retavase(R)
for acute myocardial infarction and IV Busulfex(R)
(http://www.pdlbiopharma.com/index.cfm?navid=37) (Black Box Warning) for
conditioning prior to a bone marrow transplant in association with chronic
In addition to its marketed products, PDL has a novel antibody-focused
proprietary pipeline, with a therapeutic focus in inflammation and
autoimmune diseases, oncology, and cardiovascular disorders. The company's
pioneering antibody humanization technology has also enabled nine products
to be marketed in the United States.
About the Emergency Nurses Association
The Emergency Nurses Association (ENA) is the only professional nursing
association dedicated to defining the future of emergency nursing and
emergency care through advocacy, expertise, innovation, and leadership.
Founded in 1970, ENA serves as the voice of more than 32,000 members and
their patients through research, publications, professional development,
injury prevention, and patient education. Additional information is
available at ENA's Web site, at http://www.ena.org.
SOURCE Emergency Nurses Association